GGrantIndex
← Leaderboards

Richard Yi

Univ Of Arkansas For Med Scis

$5,408,466
Attributed
$5,915,182
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $815.3K · FY200724
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,915,182 · 7

By mechanism

R01$3,603,436 · 2
R34$726,124 · 1
R56$694,576 · 1
K02$603,611 · 1
R03$287,435 · 2

Top collaborators

Others in their field

Top investigators on “Discounting

Research focus

DiscountingInsightFutureDrug UsagePreferenceDecision MakingRewardsTrainingExecutive FunctionPreventParticipantProceduresBaseFundingDiscountRelapseCigarette SmokerCigarette SmokingAbstinenceSmokingInnovationExhibitsFollow-UpLiterature

Grant awards (27)

Improving Decision Making to Prevent Substance Misuse among Adolescents from Traditionally Underserved Communities$229,073
R34 · FY2024 · DA
Improving Decision Making to Prevent Substance Misuse among Adolescents from Traditionally Underserved Communities$234,911
R34 · FY2023 · DA
Improving Decision Making to Prevent Substance Misuse among Adolescents from Traditionally Underserved Communities$262,140
R34 · FY2022 · DA
Remediation of elevated delay discounting in mid-life individuals: A stage-II trial$436,897
R01 · FY2021 · AG · contact PI
Remediation of elevated delay discounting in mid-life individuals: A stage-II trial$56,165
R01 · FY2020 · AG · contact PI
Remediation of elevated delay discounting in mid-life individuals: A stage-II trial$503,227
R01 · FY2019 · AG · contact PI
Remediation of elevated delay discounting in mid-life individuals: A stage-II trial$529,163
R01 · FY2018 · AG · contact PI
DEVELOPMENT OF SMOKING CESSATION INTERVENTIONS INFORMED BY TEMPORAL DISCOUNTING$78,655
K02 · FY2018 · DA · contact PI
Development of smoking cessation interventions informed by temporal discounting$42,068
K02 · FY2018 · DA · contact PI
Remediation of elevated delay discounting in mid-life individuals: A phase-II trial$694,576
R56 · FY2017 · AG · contact PI
Development of smoking cessation interventions informed by temporal discounting$120,722
K02 · FY2017 · DA · contact PI
Development of smoking cessation interventions informed by temporal discounting$76,457
K02 · FY2016 · DA · contact PI
Development of smoking cessation interventions informed by temporal discounting$44,265
K02 · FY2016 · DA · contact PI
Remediation of Elevated Delay Discounting in Mid-Life Individuals$287,309
R01 · FY2015 · AG · contact PI
Development of smoking cessation interventions informed by temporal discounting$120,722
K02 · FY2015 · DA · contact PI
Remediation of Elevated Delay Discounting in Mid-Life Individuals$299,996
R01 · FY2014 · AG · contact PI
Development of smoking cessation interventions informed by temporal discounting$120,722
K02 · FY2014 · DA · contact PI
Soft Commitment as a Mechanism to Prevent Preference Reversals in Smokers$279,360
R01 · FY2013 · DA · contact PI
Soft Commitment as a Mechanism to Prevent Preference Reversals in Smokers$327,375
R01 · FY2012 · DA · contact PI
Soft Commitment as a Mechanism to Prevent Preference Reversals in Smokers$291,000
R01 · FY2011 · DA · contact PI
Soft Commitment as a Mechanism to Prevent Preference Reversals in Smokers$211,700
R01 · FY2010 · DA · contact PI
Soft Commitment as a Mechanism to Prevent Preference Reversals in Smokers$78,300
R01 · FY2010 · DA · contact PI
Future Probability and Past Discounting by Active Methamphetamine Users$72,500
R03 · FY2009 · DA · contact PI
Future Probability and Past Discounting by Active Methamphetamine Users$72,375
R03 · FY2008 · DA · contact PI
The discounting of losses by smokers in nicotine withdrawl$70,560
R03 · FY2008 · DA · contact PI
Delay Discounting in Drug Dependence$302,944
R01 · FY2007 · DA · contact PI
The discounting of losses by smokers in nicotine withdrawl$72,000
R03 · FY2007 · DA · contact PI